HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R A Goodlad Selected Research

Neoplasms (Cancer)

10/2006Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer.
8/2004Both suboptimal and elevated vitamin intake increase intestinal neoplasia and alter crypt fission in the ApcMin/+ mouse.
9/2003Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice.
7/2001Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R A Goodlad Research Topics

Disease

4Polyps
04/2008 - 09/2003
4Neoplasms (Cancer)
10/2006 - 07/2001
2Intestinal Neoplasms (Intestinal Cancer)
04/2008 - 10/2006
2Adenoma (Adenomas)
02/2008 - 10/2006
2Colonic Neoplasms (Colon Cancer)
02/2005 - 07/2001
2Atrophy
03/2002 - 06/2000
2Colitis
07/2001 - 06/2000
1Body Weight (Weight, Body)
02/2005
1Obesity
02/2005
1Intestinal Polyps
08/2004
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
09/2003
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2002
1Carcinogenesis
08/2002
1Short Bowel Syndrome
02/2000
1Mucositis
02/2000
1Starvation
01/2000

Drug/Important Bio-Agent (IBA)

2LeptinIBA
02/2005 - 01/2000
2LectinsIBA
08/2002 - 03/2002
1Conjugated Linoleic AcidsIBA
04/2008
1EphB3 ReceptorIBA
02/2008
1cediranib (AZD2171)IBA
10/2006
1beta CateninIBA
10/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2006
1Messenger RNA (mRNA)IBA
10/2006
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2006
1Biological ProductsIBA
02/2005
1Mitogen-Activated Protein KinasesIBA
02/2005
1Vitamin A (Retinol)FDA LinkGeneric
08/2004
1VitaminsIBA
08/2004
1Folic Acid (Vitamin M)FDA LinkGeneric
08/2004
1Epidermal Growth Factor (EGF)IBA
09/2003
1MucinsIBA
08/2002
1OligosaccharidesIBA
08/2002
1CarbohydratesIBA
07/2001
1Thomsen-Friedenreich antigenIBA
07/2001
1AntigensIBA
07/2001
1Glycoproteins (Glycoprotein)IBA
07/2001
1Sepharose (Agarose)IBA
07/2001
1Tissue ExtractsIBA
07/2001
1Blood Group Antigens (Blood Groups)IBA
07/2001
1MitogensIBA
02/2000
1Fibroblast Growth Factor 7FDA Link
02/2000

Therapy/Procedure

1Total Parenteral Nutrition
06/2000
1Drug Therapy (Chemotherapy)
02/2000